Eric Eisenmann

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (13)

James Blachly

Associate Professor of Internal Medicine

Ohio State University

UNITED STATES

View details

Shelley Orwick

Ohio State University

UNITED STATES

View details

Michelle A. Rudek

Johns Hopkins University

UNITED STATES

View details

Shuiying Hu

Ohio State University

UNITED STATES

View details

Bhavana Bhatnagar

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Mitch Phelps

Ohio State University

UNITED STATES

View details

Tarek Magdy

Assistant Professor

UNITED STATES

View details

Tara Lin

University of Kansas Medical Center

UNITED STATES

View details

Bradley W. Blaser

UNITED STATES

View details

Przemysław Radwański

Assistant Professor

Ohio State University

UNITED STATES

View details

Sharyn D. Baker

Ohio State University

UNITED STATES

View details

Xiaolin Cheng

Associate Professor

Ohio State University

UNITED STATES

View details

Vincenzo Coppola

Associate Professor

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eric Eisenmann

Research Interests

Explore related searches

Contact this professor

Articles (18)

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen

Resazurin dye is an in vivo sensor of kidney tubular function.

Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport

Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS/MS method for murine plasma analysis.

Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method

Unique Cabozantinib Dosing Considerations in People Living with HIV and Cancer

BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities

Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination

Boosting the oral bioavailability of anticancer drugs through intentional drug–drug interactions

Targeting OCT3 attenuates doxorubicin-induced cardiac injury.

Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition

TP-0903 is active in models of drug-resistant acute myeloid leukemia

Collaborators (13)

James Blachly

Shelley Orwick

Michelle A. Rudek

Shuiying Hu

Bhavana Bhatnagar

Mitch Phelps

Tarek Magdy

Tara Lin

Bradley W. Blaser

Przemysław Radwański

Sharyn D. Baker

Xiaolin Cheng

Vincenzo Coppola

Make your next move.